Use of lipid conjugates in the treatment of inflammatory disorders

a technology of lipid conjugates and phospholipids, applied in the field of lipid conjugates and phospholipid conjugates, can solve the problems of lack of direction in the flow of blood, frequent emptying of vessels, and formation of small capillaries, and achieve the effect of inhibiting the development of hemangioma

Inactive Publication Date: 2015-02-26
YEDGAR SAUL
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

These conjugates effectively inhibit angiogenesis, reducing tumor growth, atherosclerotic plaque formation, and inflammation, providing a broader range of pharmacological activities than traditional compounds, including protection against oxidative stress and cell damage.

Problems solved by technology

As the tumor grows and recruits more and more blood supply, a network of small capillaries forms and becomes disorganized.
There is lack of direction to the flow of blood and empty vessels form frequently.
Thus the chaotic vascular system formed results in increased pressure.
As the pressure increases these vessels become “leaky”.
Lack of oxygen, in turn, causes the cancer cells to secrete even more VEGF and propagate this vicious cycle.
As the lesions increase in size, they reduce the diameter of the arteries and impede blood circulation.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of lipid conjugates in the treatment of inflammatory disorders
  • Use of lipid conjugates in the treatment of inflammatory disorders
  • Use of lipid conjugates in the treatment of inflammatory disorders

Examples

Experimental program
Comparison scheme
Effect test

example 1

Control of Angiogenic Processes by Inhibition of Spla2 Activity

[0253]To comprehensively study the possible control of angiogenic processes by inhibition of sPLA2 activity, the effect of HyPE on HBMEC proliferation, migration and capillary formation was determined. As noted in the materials section, the medium used for cultivation of the endothelial cells is already supplemented with growth factors. To examine the effect of HyPE on growth factor-induced endothelial cell activation, the culture medium was further supplemented with bFGF, VEGF and OSM, which further increased HBMEC stimulation by about 50%, as shown below.

Effect of HyPE on HBMEC Proliferation

[0254]FIG. 1 shows that HyPE effectively inhibited HBMEC proliferation in a dose-dependent manner, whether the cells were grown in the control culture medium containing standard amount of growth factors, or stimulated with additional amount of VEGF, bFGF or OSM. At the same time, HyAc did not affect the cell proliferation. It should...

example 2

Invasive Cellular Proliferative Disorders

[0264]The Lipid-conjugates are effective therapy for cellular proliferative disorders, such as cancer. This is demonstrated in experiments 7.1-7.3 above and 8.1-8.8 below. The process of cancer spread entails multiple events, each of these is a worthy target for inhibitory drug action, including the rate of cell-proliferation, the rate of spread through blood vessels, the rate of invasiveness through contiguous and non-contiguous (metastases) tissues, and the rate of production of new blood vessels to supply the cancerous growth. Cancer cells frequently produce intracellular matrix tissue degrading enzymes which serve to enhance their invasive potential. Cancer is thus a multiphasic disease involving the process of tissue invasiveness, spread through tissue channels, angiogenesis and tumor vascularization. These latter processes depend upon the rates of proliferation of endothelial cells and smooth muscle cells.

[0265]Lipid-conjugates inhibit ...

example 3

Glycolipid Conjugates Modulate Chemokine and / or Cytokine Expression

[0279]The effects of the Lipid-conjugates were tested in the following cell lines: 16HBE, IB-3 and C-38 cells.

[0280]Studies of the pathogenesis of rheumatoid arthritis (RA) have revealed that both synovial fibroblasts and T cells participate in the perpetuation of joint inflammation as dynamic partners in a mutual activation feedback, via secretion of cytokines and chemokines that stimulate each other. IL-8 is frequently found at high levels in diseases associated with neutrophil. influx, and during the course of rheumatoid arthritis. IL-6 is frequently found at high levels in diseases associated with neutrophil. influx, and during the course of rheumatoid arthritis.

[0281]The cells were grown to confluency in 96 well plates, washed, and Lipid-conjugates (Compounds XXII, XXIII, and XXV) or sham were added to the cells, which were incubated at 37° C. for 30 minutes. Cells were washed, and in some groups, incubated with...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This invention provides for the use of compounds represented by the structure of the general formula (A):wherein L is a lipid or a phospholipid, Z is either nothing, ethanolamine, serine, inositol, choline, or glycerol, Y is either nothing or a spacer group ranging in length from 2 to 30 atoms, X is a physiologically acceptable monomer, dimer, oligomer, or polymer, wherein X is a glycosaminoglycan; and n is a number from 2 to 1000, wherein any bond between L, Z, Y and X is either an amide or an esteric bond in treating a subject suffering from a disease associated with harmful angiogenic processes such as cancer.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a divisional application of U.S. application Ser. No. 12 / 406,130, filed Mar. 18, 2009, which is hereby incorporated by reference.FIELD OF THE INVENTION[0002]This invention is directed to lipid-GAG conjugates and phospholipid-GAG conjuagtes for inhibiting angiogenesis and atherosclerosis.BACKGROUND OF THE INVENTION[0003]Angiogenesis literally means the birth of new blood vessels. (In Greek, “angio” means blood vessel and “genesis” means birth or beginning). Under controlled physiologic conditions it is a normal and essential process. For example, angiogenesis is a necessary part of fetal development, wound healing, and recovery from a heart attack. However, during the process of cancer growth and spread, angiogenesis allows the tumor to make its own blood supply in order to obtain the nutrients and oxygen it needs for survival. The result is a web of vessels that allows the tumor to grow even more and spread (metastasiz...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(United States)
IPC IPC(8): A61K47/48A61K45/06
CPCA61K45/06A61K47/48053A61K31/661A61K31/80A61K47/544A61P9/10A61P27/02A61P35/00
InventorYEDGAR, SAUL
OwnerYEDGAR SAUL